{"id":173,"date":"2013-11-15T01:58:52","date_gmt":"2013-11-14T16:58:52","guid":{"rendered":"http:\/\/preview-me.net\/m.ehime-u.ac.jp\/school\/radiology\/?post_type=results&#038;p=173"},"modified":"2020-12-16T20:34:36","modified_gmt":"2020-12-16T11:34:36","slug":"2012%e5%b9%b4%e3%80%80%e3%81%9d%e3%81%ae2%ef%bc%88%e5%ad%a6%e4%bc%9a%e7%99%ba%e8%a1%a8%e3%80%81%e8%ac%9b%e6%bc%94%e3%80%81%e7%a0%94%e7%a9%b6%e5%8a%a9%e6%88%90%e3%80%81%e5%8f%97%e8%b3%9e%ef%bc%89","status":"publish","type":"results","link":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/results\/173\/","title":{"rendered":"2012\u5e74\u3000\u305d\u306e2\uff08\u5b66\u4f1a\u767a\u8868\u3001\u8b1b\u6f14\u3001\u7814\u7a76\u52a9\u6210\u3001\u53d7\u8cde\uff09"},"content":{"rendered":"<p>\u25a0\u5b66\u4f1a\u30fb\u7814\u7a76\u4f1a\u767a\u8868<br \/>\n<a href=\"#06\">\u56fd\u5185\u5b66\u4f1a\uff08\u5168\u56fd\uff09<\/a><br \/>\n<a href=\"#07\">\u56fd\u5185\u5b66\u4f1a\uff08\u5730\u65b9\u4f1a\uff09<\/a><br \/>\n\u25a0 <a href=\"#08\">\u8b1b\u6f14<\/a><br \/>\n\u25a0 <a href=\"#09\">\u7814\u7a76\u52a9\u6210<\/a><br \/>\n\u25a0 <a href=\"#10\">\u53d7\u8cde<\/a><\/p>\n<p>\u8ad6\u6587\u30fb\u8457\u66f8\u3001\u56fd\u969b\u5b66\u4f1a\u767a\u8868\u306f<a href=\"..\/172\/\">2012\u5e74\u696d\u7e3e\u3000\u305d\u306e1<\/a>\u3092\u3054\u89a7\u4e0b\u3055\u3044\u3002<\/p>\n<p>&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<\/p>\n<p><strong><span style=\"color: #336699;\">\u25a0<\/span> \u5b66\u4f1a\u767a\u8868(\u56fd\u5185)<\/strong><\/p>\n<p><a id=\"06\"><\/a><span style=\"color: #d391a8;\">\u25cf<\/span> \u56fd\u5185\u5b66\u4f1a(\u5168\u56fd)<\/p>\n<ol>\n<li>\u57ce\u6238\u502b\u4e4b\uff0c\u9577\u5c3e\u5145\u5c55\uff0c\u5ddd\u53e3\u76f4\u4eba\uff0c\u8d77\u585a\u9999\u5b50\uff0c\u57ce\u6238\u8f1d\u4ec1\uff0c\u5009\u7530\u8056\uff0c\u5bae\u5ddd\u6b63\u7537\uff0c\u671b\u6708\u8f1d\u4e00\uff0eATP\u8ca0\u8377\u30bf\u30ae\u30f3\u30b0MRI\u306b\u3088\u308b\u865a\u8840\u5fc3\u7b4b\u306e\u58c1\u904b\u52d5\u8a55\u4fa1\uff0e\u7b2c22\u56de\u65e5\u672c\u5fc3\u8840\u7ba1\u753b\u50cf\u52d5\u614b\u5b66\u4f1a\uff082012.1 \u540d\u53e4\u5c4b\uff09<\/li>\n<li>\u8d77\u585a\u9999\u5b50, \u57ce\u6238\u502b\u4e4b, \u5ddd\u53e3\u76f4\u4eba, \u57ce\u6238\u8f1d\u4ec1, \u5009\u7530\u8056, \u5bae\u5ddd\u6b63\u7537, \u671b\u6708\u8f1d\u4e00\u3000\u8ca0\u8377\u5fc3\u7b4b perfusion MRI\u306b\u3066\u5fae\u5c0f\u5faa\u74b0\u969c\u5bb3\u304c\u793a\u5506\u3055\u308c\u305fprobable microscopic polyangitis\u306e\u4e00\u4f8b\u3000\u7b2c22\u56de\u65e5\u672c\u5fc3\u8840\u7ba1\u753b\u50cf\u52d5\u614b\u5b66\u4f1a(2012.1, \u540d\u53e4\u5c4b)<\/li>\n<li>\u5c0f\u4e80\u96c5\u5e83\uff0c\u4e95\u4e0a\u6b66\uff0c\u4e09\u597d\u5fb9\uff0c\u677e\u7530\u5353\u4e5f\uff0c\u5c71\u5d0e\u6d69\u5b9f\uff0c\u7a32\u6708\u5343\u5c0b\uff0c\u6751\u4e0a\u5fe0\u53f8\uff0c\u66fd\u6211\u90e8\u4e00\u90ce\uff0c\u77f3\u4e38\u826f\u5e83\uff0c\u677e\u6728\u5f18\u91cf\uff0c\u4e2d\u6751\u8aa0\u6cbb\uff0c\u4e09\u6728\u5747. IgG4\u95a2\u9023\u75be\u60a3\u306e\u4e00\u4f8b.\u7b2c116\u56de\u6838\u533b\u5b66\u75c7\u4f8b\u691c\u8a0e\u4f1a\uff082012.2.\u5c3c\u5d0e\uff09<\/li>\n<li>\u5e73\u585a\u7fa9\u5eb7, \u4e09\u6728\u5747, \u83ca\u6c60\u6075\u4e00, \u5c0f\u7530\u5c1a\u543e, \u7a32\u6708\u5343\u5c0b, \u671b\u6708\u8f1d\u4e00\uff0e\uff13\u30c6\u30b9\u30e9MRI\u3092\u7528\u3044\u305f3D TOF MRA\u306b\u3088\u308b\u508d\u6b63\u4e2d\u52d5\u8108\u63cf\u51fa\u80fd\u306e\u691c\u8a0e\uff0e\u7b2c41\u56de\u65e5\u672c\u795e\u7d4c\u653e\u5c04\u7dda\u5b66\u4f1a(2012\uff0e2\uff0c\u5fd7\u6469)<\/li>\n<li>\u7a32\u6708\u5343\u5c0b\uff0c\u4e09\u6728\u5747\uff0c\u6751\u4e0a\u5fe0\u53f8\uff0c\u66fd\u6211\u90e8\u4e00\u90ce\uff0c\u77f3\u4e38\u826f\u5e83\uff0c\u5ca1\u672c\u61b2\u7701. \u6025\u6027\u671f\u8996\u5e8a\u6897\u585e\u306b\u304a\u3051\u308bMRI\u306e\u691c\u8a0e.\u7b2c41\u56de\u65e5\u672c\u795e\u7d4c\u653e\u5c04\u7dda\u5b66\u4f1a(2012.2.\u5fd7\u6469)<\/li>\n<li>\u4e09\u6728\u5747. \u5148\u5929\u6027\u810a\u9ac4\u816b\u760d\u306e\uff11\u4f8b. \u7b2c4\u56de\u810a\u690e\u30fb\u810a\u9ac4\u753b\u50cf\u30af\u30e9\u30d6(2012.3. \u6771\u4eac)<\/li>\n<li>Kido TO, Nagao M, Okizuka Y, Kawaguchi N, Kido TE, Kurata A, Miyagawa M, Mochizuki T. Detection of Coronary Artery Disease Using ATP-stress Cine-tagging MRI:\u3000Comparison to ATP-stress Perfusion MRI. \u7b2c76\u56de \u65e5\u672c\u5faa\u74b0\u5668\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a(2012.3, \u798f\u5ca1)<\/li>\n<li>\u8d77\u585a\u9999\u5b50, \u5bae\u5ddd\u6b63\u7537, \u5ddd\u53e3\u76f4\u4eba, \u57ce\u6238\u502b\u4e4b, \u5009\u7530\u8056, \u57ce\u6238\u8f1d\u4ec1,\u671b\u6708\u8f1d\u4e00\u3000\u65b0\u3057\u3044\u5fc3\u81d3\u7528\u534a\u5c0e\u4f53SPECT\u88c5\u7f6e\u306e\u6709\u7528\u6027\uff1a\u5f93\u6765\u578bSPECT\u3068\u306e\u6bd4\u8f03\uff0e\u7b2c76\u56de \u65e5\u672c\u5faa\u74b0\u5668\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a(2012.3, \u798f\u5ca1)<\/li>\n<li>\u6d25\u7530\u5b5d\u6cbb,\u6b66\u667a\u6075,\u83c5\u539f\u656c\u6587,\u7530\u4e2d\u5b8f\u660e,\u6751\u4e0a\u6b63\u54f2,\u671b\u6708\u8f1d\u4e00\uff0e\u5c0f\u8178\u816b\u760d\u306eCT\u8a3a\u65ad\uff0e\u7b2c71\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a (2012.4, \u6a2a\u6d5c)<\/li>\n<li>\u9ad8\u6a4b\u5fe0\u7ae0, \u83c5\u539f\u656c\u6587, \u9152\u4e95\u4f38\u4e5f, \u6e05\u6c34\u8f1d\u5f66, \u68b6\u539f\u3000\u8aa0, \u7d30\u5ddd\u6d69\u5e73, \u7530\u908a\u88d5\u8cb4\uff0e\u91cd\u8907\u764c\u30fb\u91cd\u8907\u75c5\u5909\u306e\u753b\u50cf\u8a3a\u65ad\uff1aFDG-PET\/CT\u3092\u4e2d\u5fc3\u306b\uff0e\u7b2c71\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a (2012.4, \u6a2a\u6d5c)<\/li>\n<li>\u5175\u982d\u670b\u5b50, \u5ca1\u7530\u771f\u5e83, \u77e2\u7530\u5178\u4e45, \u5de5\u85e4\u6b63\u5e78, \u9999\u5ddd\u7950\u6bc5, \u718a\u91ce\u6b63\u58eb, \u77f3\u4e95\u4e00\u6210, \u5de5\u85e4\u6b63\u4fca, \u6751\u4e0a\u5353\u9053. Dual energy CT\u3092\u7528\u3044\u305f\u809d\u8102\u80aa\u306e\u5b9a\u91cf\u8a55\u4fa1\uff1a\u30d5\u30a1\u30f3\u30c8\u30e0\u5b9f\u9a13\u3068\u521d\u671f\u81e8\u5e8a\u7d4c\u9a13. \u7b2c71\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a (2012.4, \u6a2a\u6d5c)<\/li>\n<li>\u5c0f\u7530\u5c1a\u543e\uff0c\u5bae\u5ddd\u6b63\u7537\uff0c\u795e\u5d0e\u535a\u5141\uff0c\u5e73\u585a\u7fa9\u5eb7\uff0c\u83ca\u6c60\u6075\u4e00\uff0c\u671b\u6708\u8f1d\u4e00\uff0c\u6e21\u9089\u82f1\u662d\uff0c\u4e45\u9580\u826f\u660e\uff0eEvaluation of quantitative cerebral blood flow 123I-IMP SPECT with ACZ challenging: Comparison between different detectors. \u7b2c71\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a (2012.4, \u6a2a\u6d5c)<\/li>\n<li>\u6b66\u667a\u6075, \u6d25\u7530\u5b5d\u6cbb, \u7530\u4e2d\u5b8f\u660e, \u5409\u5ca1\u771f\u4e8c, \u6751\u7530\u7e41\u5229, \u671b\u6708\u8f1d\u4e00. EOB\u9020\u5f71MRI\u809d\u7d30\u80de\u76f8\u3067\u7b49\uff5e\u9ad8\u4fe1\u53f7\u306a\u4e4f\u8840\u6027\u7d50\u7bc0\u306e\u7d4c\u904e\u306b\u3064\u3044\u3066. \u7b2c71\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a (2012.4, \u6a2a\u6d5c)<\/li>\n<li>\u7530\u53e3\u5343\u85cf, \u6ff1\u672c\u3000\u6cf0, \u795e\ufa11\u535a\u5145, \u4e0a\u6d25\u5b5d\u592a\u90ce, \u897f\u5ddd\u3000\u6566, \u672c\u7530\u5f18\u6587, \u91cd\u677e\u5065\u5409, \u671b\u6708\u8f1d\u4e00, \u4ed6. \u524d\u51e6\u7f6e\u8efd\u6e1b\u79fb\u690d\u306b\u304a\u3051\u308b\u5316\u5b66\u7642\u6cd5\u3068\u7d44\u307f\u5408\u308f\u305b\u305f\u4f4e\u7dda\u91cf\u5168\u8eab\u7167\u5c04\u306b\u95a2\u3059\u308b\u691c\u8a0e. \u7b2c71\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a (2012.4, \u6a2a\u6d5c)<\/li>\n<li>\u7a32\u6708\u5343\u5c0b\uff0c\u4e09\u6728\u5747\uff0c\u6751\u4e0a\u5fe0\u53f8\uff0c\u66fd\u6211\u90e8\u4e00\u90ce\uff0c\u77f3\u4e38\u826f\u5e83\uff0c\u83ca\u6c60\u9686\u5fb3\uff0c\u4e95\u4e0a\u6b66\uff0c\u4e2d\u6751\u8aa0\u6cbb\uff0c\u5ca1\u672c\u61b2\u7701. \u6025\u6027\u671f\u4e21\u5074\u8996\u5e8a\u6897\u585e\u306b\u304a\u3051\u308bMRI\u306e\u691c\u8a0e. \u7b2c71\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a (2012.4, \u6a2a\u6d5c)<\/li>\n<li>Kido TO, Nagao M, Okizuka Y, Kawaguchi N, Kido TE, Kurata A, Miyagawa M, Mochizuki T. Detection of Coronary Artery Disease Using ATP-stress Cine-tagging MRI: Comparison to ATP-stress Perfusion MRI. \u7b2c71\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a (2012.4, \u6a2a\u6d5c)<\/li>\n<li>\u897f\u5c71\u9999\u5b50\uff0c\u5bae\u5ddd\u6b63\u7537\uff0c\u4e2d\u6751\u58ee\u5fd7\uff0c\u677e\u7530\u5353\u4e5f\uff0c\u5ddd\u53e3\u76f4\u4eba\uff0c\u57ce\u6238\u502b\u4e4b\uff0c\u57ce\u6238\u8f1d\u4ec1\uff0c\u5009\u7530\u8056\uff0c\u671b\u6708\u8f1d\u4e00 \u534a\u5c0e\u4f53\u691c\u51fa\u5668SPECT\u306b\u3088\u308bSupine-Prone\u50cf\u3092\u7528\u3044\u305f\u5fc3\u7b4b\u865a\u8840\u8a55\u4fa1\u3000\u7b2c22\u56de \u65e5\u672c\u5fc3\u81d3\u6838\u533b\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u5927\u4f1a (2012.6, \u91d1\u6ca2)<\/li>\n<li>\u897f\u5c71\u9999\u5b50, \u5bae\u5ddd\u6b63\u7537, \u5ddd\u53e3\u76f4\u4eba, \u57ce\u6238\u502b\u4e4b, \u5009\u7530\u8056, \u57ce\u6238\u8f1d\u4ec1,\u671b\u6708\u8f1d\u4e00\u3000\u65b0\u3057\u3044\u5fc3\u81d3\u7528\u534a\u5c0e\u4f53SPECT\u88c5\u7f6e\u306e\u6709\u7528\u6027\uff1a\u5f93\u6765\u578bSPECT\u3068\u306e\u6bd4\u8f03. \u7b2c71\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a (2012.4, \u6a2a\u6d5c)<\/li>\n<li>\u7a32\u6708\u5343\u5c0b\uff0c\u4e09\u6728\u5747\uff0c\u5c0f\u7530\u5c1a\u543e\uff0c\u5e73\u585a\u7fa9\u5eb7\uff0c\u83ca\u6c60\u6075\u4e00\uff0c\u671b\u6708\u8f1d\u4e00\uff0c\u6850\u5c71\u90c1\u5b50. \u982d\u90e8CT\u306b\u304a\u3051\u308b\u9010\u6b21\u8fd1\u4f3c\u6cd5\u306e\u521d\u671f\u4f7f\u7528\u7d4c\u9a13. \u7b2c2\u56deAdvanced CT\u30fbMRI\u7814\u7a76\u4f1a(2012. 6. \u8efd\u4e95\u6ca2)<\/li>\n<li>\u5c0f\u7530\u5c1a\u543e\uff0c\u4e09\u6728\u5747. Desmoplastic infantile astrocytoma\u306e\u4e00\u4f8b. \u7b2c32\u56de\u795e\u7d4c\u653e\u5c04\u7dda\u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d7(2012.6.\u821e\u6d5c)<\/li>\n<li>\u5409\u5ca1\u771f\u4e8c\uff0c\u795e\u5d0e\u535a\u5145\uff0c\u798f\u5c71\u76f4\u7d00\uff0c\u5e73\u7530\u96c5\u662d\uff0c\u6d66\u5cf6\u96c4\u4ecb\uff0c\u6751\u7530\u7e41\u5229. IPNB\u7531\u6765\u6d78\u6f64\u764c\uff1a\uff13\u75c7\u4f8b\u306e\u753b\u50cf\u6240\u898b\u306e\u691c\u8a0e\uff0e\u7b2c26\u56de\u8179\u90e8\u653e\u5c04\u7dda\u7814\u7a76\u4f1a\uff082012.6,\u5927\u962a\uff09<\/li>\n<li>\u6e05\u6c34\u8f1d\u5f66\uff0c\u83c5\u539f\u656c\u6587\uff0c\u7530\u908a\u88d5\u8cb4\uff0c\u7d30\u5ddd\u6d69\u5e73\uff0c\u68b6\u539f\u3000\u8aa0\uff0c\u9ad8\u6a4b\u5fe0\u7ae0\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u7be0\u68ee\u5065\u4ecb\uff0c\u6a4b\u6839\u52dd\u7fa9\uff0c\u5bfa\u672c\u5178\u5f18\uff0e\u5de8\u5927\u306a\u814e\u826f\u6027\u9593\u8449\u7cfb\u816b\u760d\u306e1\u4f8b\uff0e\u7b2c26\u56de\u8179\u90e8\u653e\u5c04\u7dda\u7814\u7a76\u4f1a\uff082012.6,\u5927\u962a\uff09<\/li>\n<li>\u6b66\u667a\u6075, \u6d25\u7530\u5b5d\u6cbb, \u4f50\u3005\u6728\u793c\u7f8e, \u7530\u4e2d\u5b8f\u660e, \u671b\u6708\u8f1d\u4e00, \u4ed6. \u8853\u524d\u306eFDG-PET\u3067\u4f4e\u96c6\u7a4d\u3092\u793a\u3057\u8a3a\u65ad\u306b\u82e6\u616e\u3057\u305f\u526f\u814e\u76ae\u8cea\u764c\u306e1\u4f8b. \u7b2c26\u56de\u8179\u90e8\u653e\u5c04\u7dda\u7814\u7a76\u4f1a\uff082012.6,\u5927\u962a\uff09<\/li>\n<li>\u7530\u908a\u88d5\u8cb4\uff0c\u83c5\u539f\u656c\u6587\uff0c\u7d30\u5ddd\u6d69\u5e73\uff0c\u68b6\u539f\u3000\u8aa0\uff0c\u6e05\u6c34\u8f1d\u5f66\uff0c\u9ad8\u6a4b\u5fe0\u7ae0\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u5927\u7530\u8015\u53f8\uff0c\u68da\u7530\u3000\u7a14\uff0c\u7058\u91ce\u6210\u4eba\uff0c\u897f\u6751\u7406\u6075\u5b50\uff0e\uff13\u5e74\u7d4c\u904e\u3092\u8ffd\u3048\u305fIPN-B\u306e1\u4f8b\uff0e\u7b2c26\u56de\u8179\u90e8\u653e\u5c04\u7dda\u7814\u7a76\u4f1a\uff082012.6\u3000\u5927\u962a\uff09\u5175\u982d\u670b\u5b50, \u5ca1\u7530\u771f\u5e83, \u9999\u5ddd\u7950\u6bc5, \u65e5\u9ad8\u6b63\u4e8c\u90ce, \u4efb\u8aa0\u96f2, \u67f3\u751f\u884c\u4f38, \u4e0a\u5d8b\u4e00\u81e3, \u77e2\u7530\u5178\u4e45, \u5de5\u85e4\u6b63\u5e78, \u77f3\u4e95\u4e00\u6210, \u5de5\u85e4\u6b63\u4fca, \u6751\u4e0a\u5353\u9053. \u809d\u8840\u884c\u52d5\u614b\u89e3\u6790\u306b\u3088\u308b\u30bd\u30e9\u30d5\u30a7\u30cb\u30d6\u6cbb\u7642\u52b9\u679c\u306e\u65e9\u671f\u4e88\u6e2c\uff0dCT perfusion\u3092\u7528\u3044\u3066. \u7b2c48\u56de\u65e5\u672c\u809d\u764c\u7814\u7a76\u4f1a (2012.7, \u91d1\u6ca2)<\/li>\n<li>\u677e\u7530\u5353\u4e5f, \u5bae\u5ddd\u6b63\u7537, \u4e2d\u6751\u58ee\u5fd7, \u897f\u5c71\u9999\u5b50, \u5ddd\u53e3\u76f4\u4eba, \u57ce\u6238\u502b\u4e4b, \u57ce\u6238\u8f1d\u4ec1, \u5009\u7530 \u8056, \u671b\u6708\u8f1d\u4e00. \u5fc3\u623f\u7d30\u52d5\u60a3\u8005\u306b\u304a\u3051\u308b\u5fc3\u81d3\u3078\u306eF-18 FDG\u96c6\u7a4d\u306e\u7279\u5fb4. \u7b2c75\u56de\u65e5\u672c\u5fc3\u81d3\u8840\u7ba1\u653e\u5c04\u7dda\u7814\u7a76\u4f1a(2012.7, \u6771\u4eac)<\/li>\n<li>\u83ca\u6c60\u9686\u5fb3\uff0c\u4e2d\u6751\u8aa0\u6cbb\uff0c\u4e95\u4e0a\u6b66\uff0c\u6d77\u8001\u539f\u308b\u3044\uff0c\u4e09\u597d\u5fb9\uff0c\u5c71\u5d0e\u6d69\u5b9f\uff0c\u7a32\u6708\u5343\u5c0b\uff0c\u5c0f\u7530\u5c1a\u543e\uff0c\u6751\u4e0a\u5fe0\u53f8\uff0c\u66fd\u6211\u90e8\u4e00\u90ce\uff0c\u77f3\u4e38\u826f\u5e83\uff0c\u677e\u6728\u5f18\u91cf\uff0c\u4e09\u6728\u5747.PET-CT\u3067\u767a\u898b\u3055\u308c\u305f\u526f\u7532\u72b6\u817a\u6a5f\u80fd\u4ea2\u9032\u75c7\u306e\u4e00\u4f8b. \u7b2c117\u56de\u6838\u533b\u5b66\u75c7\u4f8b\u691c\u8a0e\u4f1a\uff082012.8.\u5c3c\u5d0e\uff09<\/li>\n<li>\u9152\u4e95\u4f38\u4e5f\uff0c\u83c5\u539f\u656c\u6587\uff0c\u7530\u908a\u88d5\u8cb4\uff0c\u7d30\u5ddd\u6d69\u5e73\uff0c\u68b6\u539f\u3000\u8aa0\uff0c\u6e05\u6c34\u8f1d\u5f66\uff0c\u9ad8\u6a4b\u5fe0\u7ae0\uff0c\u6a2a\u5c71\u3000\u9686\uff0c\u91ce\u6cb3\u5b5d\u5145\uff0c\u9ad8\u7551\u6d69\u4e4b\uff0c\u5bfa\u672c\u5178\u5f18\uff0e\u8853\u524d\u8a3a\u65ad\u53ef\u80fd\u3067\u3042\u3063\u305f\u5375\u7ba1\u764c\u306e1\u4f8b\uff0e JSAWI2012, 13th Annual Symposium (2012.9\u3000\u6de1\u8def)<\/li>\n<li>\u6e05\u6c34\u8f1d\u5f66, \u7530\u908a\u88d5\u8cb4, \u7d30\u5ddd\u6d69\u5e73, \u68b6\u539f\u3000\u8aa0, \u9ad8\u6a4b\u5fe0\u7ae0, \u9152\u4e95\u4f38\u4e5f, \u83c5\u539f\u656c\u6587, \u6e05\u85e4\u4f50\u77e5\u5b50, \u5927\u4f4f\u7701\u4e09, \u897f\u6751\u7406\u6075\u5b50\uff0e\u9020\u5f71MRI\u3067\u306e\u4e73\u764cDCIS\u306e\u62e1\u304c\u308a\u8a3a\u65ad\u306b\u3064\u3044\u3066\u306e\u691c\u8a0e\uff0e\u7b2c40\u56de\u65e5\u672c\u78c1\u6c17\u5171\u9cf4\u533b\u5b66\u4f1a\u5927\u4f1a\uff082012.9\u3000\u4eac\u90fd\uff09<\/li>\n<li>\u5c0f\u7530\u5c1a\u543e\uff0c\u83ca\u6c60\u6075\u4e00\uff0c\u5e73\u585a\u7fa9\u5eb7\uff0c\u671b\u6708\u8f1d\u4e00\uff0c\u6e21\u9089\u82f1\u662d\uff0c\u4e45\u9580\u826f\u660e\uff0eAcetazolamide\u8ca0\u8377\u3092\u4f75\u7528\u3057\u305fDSC-MRI\u306b\u3088\u308b\u8133\u8840\u7ba1\u53cd\u5fdc\u6027\u306e\u8a55\u4fa1\uff1aVOF\u306b\u3088\u308b\u88dc\u6b63\u3092\u7528\u3044\u3066\uff0e\u7b2c40\u56de\u65e5\u672c\u78c1\u6c17\u5171\u9cf4\u533b\u5b66\u4f1a\u5927\u4f1a(2012. 9, \u4eac\u90fd)<\/li>\n<li>\u7a32\u6708\u5343\u5c0b\uff0c\u4e09\u6728\u5747\uff0c\u5c0f\u7530\u5c1a\u543e\uff0c\u66fd\u6211\u90e8\u4e00\u90ce\uff0c\u77f3\u4e38\u826f\u5e83\uff0c\u5ca1\u672c\u61b2\u7701. \u6025\u6027\u671f\u4e21\u5074\u8996\u5e8a\u6897\u585e\u306b\u304a\u3051\u308bMRA\u306e\u691c\u8a0e. \u7b2c40\u56de\u65e5\u672c\u78c1\u6c17\u5171\u9cf4\u533b\u5b66\u4f1a\u5927\u4f1a(2012.9.\u4eac\u90fd)<\/li>\n<li>\u677e\u7530\u5353\u4e5f,\u5009\u7530\u8056, \u4e2d\u6751\u58ee\u5fd7, \u5ddd\u53e3\u76f4\u4eba, \u897f\u5c71\u9999\u5b50, \u57ce\u6238\u502b\u4e4b, \u57ce\u6238\u8f1d\u4ec1, \u897f\u6751\u548c\u4e45, \u4e95\u4e0a\u52dd\u6b21, \u9234\u6728\u7d14 ,\u5927\u6728\u5143\u660e\u7fa9, \u6a9c\u57a3\u5be6\u7537, \u5bae\u5ddd\u6b63\u7537, \u671b\u6708 \u8f1d\u4e00. ATP\u8ca0\u8377\u30c0\u30a4\u30ca\u30df\u30c3\u30af\u5fc3\u7b4b\u304b\u3093\u6d41CT\u306b\u304a\u3051\u308b\u5b9a\u6027\u8a55\u4fa1\u3068\u5b9a\u91cf\u8a55\u4fa1\u306e\u95a2\u4fc2. \u7b2c61\u56de\u65e5\u672c\u5fc3\u81d3\u75c5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a(2012,9. \u91d1\u6ca2)<\/li>\n<li>\u5c71\u672c\u5c1a\u5e78\uff0e\u6587\u90e8\u79d1\u5b66\u7701\u4e8b\u696d\u306e\u88ab\u3070\u304f\u533b\u7642\u7814\u4fee\uff0e\u7b2c16\u56de\u653e\u5c04\u7dda\u4e8b\u6545\u533b\u7642\u7814\u7a76\u4f1a(2012.9, \u5343\u8449)<\/li>\n<li>\u83c5\u539f\u656c\u6587, \u7530\u908a\u88d5\u8cb4, \u7d30\u5ddd\u6d69\u5e73, \u68b6\u539f\u3000\u8aa0, \u6e05\u6c34\u8f1d\u5f66, \u9ad8\u6a4b\u5fe0\u7ae0, \u9152\u4e95\u4f38\u4e5f\uff0e\u80c6\u56a2\u764c\u8a3a\u7642\u306b\u304a\u3051\u308bFDG-PET\/CT\u306e\u6709\u7528\u6027\u3084\u554f\u984c\u70b9\u306b\u3064\u3044\u3066\uff0e\u7b2c48\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a\uff082012.9\u3000\u9577\u5d0e\uff09<\/li>\n<li>\u6e05\u6c34\u8f1d\u5f66, \u7530\u908a\u88d5\u8cb4, \u7d30\u5ddd\u6d69\u5e73, \u68b6\u539f\u3000\u8aa0, \u9ad8\u6a4b\u5fe0\u7ae0, \u9152\u4e95\u4f38\u4e5f, \u83c5\u539f\u656c\u6587, \u9ad8\u5d8b\u6210\u8f1d, \u5927\u4f4f\u7701\u4e09, \u897f\u6751\u7406\u6075\u5b50\uff0e\u786c\u5316\u6027\u817a\u75c7\u3092\u80cc\u666f\u306b\u4e21\u5074\u4e73\u817a\u306b\u540c\u6642\u767a\u751f\u3057\u305fDCIS\u306e1\u4f8b\uff0e\u7b2c48\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a\uff082012.9\u3000\u9577\u5d0e\uff09<\/li>\n<li>\u798f\u5c71\u76f4\u7d00, \u5409\u5ca1\u771f\u4e8c, \u795e\u5d0e\u535a\u5145, \u5e73\u7530\u96c5\u662d, \u6d66\u5cf6\u96c4\u4ecb, \u6751\u7530\u7e41\u5229. \u81b5\u306b\u96a3\u63a5\u3057\u305f\u30ea\u30f3\u30d1\u88c5\u7f6e\u306b\u5c40\u5728\u3057\u305f\u6ffe\u80de\u6027\u30ea\u30f3\u30d1\u816b\u306e\u7a00\u306a1\u4f8b. 48\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a(2012.9, \u9577\u5d0e)<\/li>\n<li>\u795e\u5d0e\u535a\u5145, \u5409\u5ca1\u771f\u4e8c, \u798f\u5c71\u76f4\u7d00, \u5e73\u7530\u96c5\u662d, \u6d66\u5cf6\u7950\u4ecb, \u6751\u7530\u7e41\u5229. MTX\u95a2\u9023\u30ea\u30f3\u30d1\u5897\u6b96\u6027\u75be\u60a3\u306e6\u75c7\u4f8b\u306e\u691c\u8a0e. \u7b2c48\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a(2012. 9, \u9577\u5d0e)<\/li>\n<li>\u7530\u908a\u88d5\u8cb4\uff0c\u7d30\u5ddd\u6d69\u5e73\uff0c\u68b6\u539f\u3000\u8aa0\uff0c\u6e05\u6c34\u8f1d\u5f66\uff0c\u9ad8\u6a4b\u5fe0\u7ae0\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u83c5\u539f\u656c\u6587\uff0c\u6fa4\u7530\u8302\u6a39\uff0c\u5c71\u4e0b\u7d20\u5f18\uff0c\u897f\u6751\u7406\u6075\u5b50\uff0e\u8457\u660e\u306aFDG\u9ad8\u96c6\u7a4d\u3092\u793a\u3057\u305foncocytic carcinoid\u306e1\u4f8b\uff0e\u7b2c26\u56de\u80f8\u90e8\u653e\u5c04\u7dda\u7814\u7a76\u4f1a\uff082012.9\u3000\u9577\u5d0e\uff09<\/li>\n<li>\u6751\u4e0a\u5fe0\u53f8\uff0c\u77f3\u4e38\u826f\u5e83\uff0c\u7a32\u6708\u5343\u5c0b\uff0c\u66fd\u6211\u90e8\u4e00\u90ce\uff0c\u83ca\u6c60\u9686\u5fb3\uff0c\u4e95\u4e0a\u6b66\uff0c\u4e09\u6728\u5747.Closed-loop\u306b\u62e1\u5f35\u306e\u8a8d\u3081\u3089\u308c\u306a\u304b\u3063\u305f\u7d5e\u627c\u6027\u30a4\u30ec\u30a6\u30b9\u306e4\u4f8b. \u7b2c22\u56de\u65e5\u672c\u6551\u6025\u653e\u5c04\u7dda\u7814\u7a76\u4f1a(2012.9.\u9577\u5d0e)<\/li>\n<li>\u7d30\u5ddd\u6d69\u5e73, \u83c5\u539f\u656c\u6587, \u68b6\u539f\u3000\u8aa0, \u6e05\u6c34\u8f1d\u5f66, \u9ad8\u6a4b\u5fe0\u7ae0, \u9152\u4e95\u4f38\u4e5f, \u6e05\u85e4\u4f50\u77e5\u5b50\uff0eFDG-PET\/CT\u306b\u3088\u308b\u4e73\u764c\u8853\u524d\u5316\u5b66\u7642\u6cd5\u306e\u52b9\u679c\u5224\u5b9a\u3068\u4e88\u5f8c\u3068\u306e\u95a2\u9023\uff0e\u7b2c\u7b2c52\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a (2012.10, \u672d\u5e4c)<\/li>\n<li>\u83c5\u539f\u656c\u6587, \u7d30\u5ddd\u6d69\u5e73, \u9152\u4e95\u4f38\u4e5f, \u9ad8\u6a4b\u5fe0\u7ae0, \u6e05\u6c34\u8f1d\u5f66, \u68b6\u539f\u3000\u8aa0, \u6e05\u85e4\u4f50\u77e5\u5b50\uff0eFDG-PET\/CT\u306b\u3088\u308b\u4e73\u764c\u8853\u524d\u5316\u5b66\u7642\u6cd5\u306e\u52b9\u679c\u5224\u5b9a-\u75c5\u7406\u5b66\u7684\u5b8c\u5168\u594f\u52b9\u306e\u57fa\u6e96\u306b\u3088\u308b\u9055\u3044\uff0e\u7b2c52\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a (2012.10, \u672d\u5e4c)<\/li>\n<li>\u5175\u982d\u670b\u5b50, \u77f3\u4e95\u4e00\u6210, \u5742\u53e3\u5065\u592a, \u82b1\u5ca1\u5b8f\u5e73, \u5b87\u4f50\u7f8e\u516c\u7537, \u5cf6\u5143\u5065\u6b21, \u5c71\u6dfb\u8b72, \u5c71\u7530\u7a63, \u677e\u6728\u5145, \u7d30\u91ce\u771e, \u6751\u4e0a\u5353\u9053. \u8a8d\u77e5\u75c7\u306b\u304a\u3051\u308b\u8133FDG-PET\u65e9\u671f\u64ae\u50cf\u306e\u53ef\u80fd\u6027\u306b\u3064\u3044\u3066. \u7b2c52\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a. \u7b2c52\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a (2012.10, \u672d\u5e4c)<\/li>\n<li>\u4e2d\u5cf6\u76f4\u7f8e, \u7d30\u5ddd\u6d69\u5e73, \u9ad8\u6a4b\u5fe0\u7ae0, \u9152\u4e95\u4f38\u4e5f, \u83c5\u539f\u656c\u6587\uff0e\u6cbb\u7642\u524dFDG-PET\/CT\u306b\u3088\u308b\u5c40\u6240\u9032\u884c\u4e73\u764c\u8853\u5f8c\u7167\u5c04\u4f8b\u306b\u304a\u3051\u308b\u518d\u767a\u4e88\u6e2c\u306e\u691c\u8a0e\uff0e\u7b2c52\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\uff082012.10\u3000\u672d\u5e4c\uff09<\/li>\n<li>\u897f\u5c71\u9999\u5b50\uff0c\u5bae\u5ddd\u6b63\u7537\uff0c\u4e2d\u6751\u58ee\u5fd7\uff0c\u677e\u7530\u5353\u4e5f\uff0c\u5ddd\u53e3\u76f4\u4eba\uff0c\u57ce\u6238\u502b\u4e4b\uff0c\u57ce\u6238\u8f1d\u4ec1\uff0c\u5009\u7530\u8056\uff0c\u671b\u6708\u8f1d\u4e00 \u534a\u5c0e\u4f53\u691c\u51fa\u5668SPECT\u306b\u3088\u308bSupine-Prone\u50cf\u3092\u7528\u3044\u305f\u5fc3\u7b4b\u865a\u8840\u8a55\u4fa1\uff0e\u7b2c52\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a (2012.10, \u672d\u5e4c)<\/li>\n<li>\u897f\u5c71\u9999\u5b50\uff0c\u5bae\u5ddd\u6b63\u7537\uff0c\u4e2d\u6751\u58ee\u5fd7\uff0c\u677e\u7530\u5353\u4e5f\uff0c\u5ddd\u53e3\u76f4\u4eba\uff0c\u57ce\u6238\u502b\u4e4b\uff0c\u57ce\u6238\u8f1d\u4ec1\uff0c\u5009\u7530\u8056\uff0c\u671b\u6708\u8f1d\u4e00 \u5fc3\u81d3\u7528\u534a\u5c0e\u4f53SPECT\u3068256\u5217\u51a0\u52d5\u8108CT angiography\u3092\u7528\u3044\u305fSPECT\/CT fusion\u753b\u50cf\u306e\u8a55\u4fa1\uff0e\u7b2c52\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a (2012.10, \u672d\u5e4c)<\/li>\n<li>\u677e\u672c\u7f8e\u6075, \u83c5\u539f\u656c\u6587, \u9152\u4e95\u4f38\u4e5f, \u9ad8\u6a4b\u5fe0\u7ae0, \u6e05\u6c34\u8f1d\u5f66, \u68b6\u539f\u3000\u8aa0, \u7d30\u5ddd\u6d69\u5e73\uff0eFDG-PET\/CT\u691c\u67fb\u306b\u304a\u3051\u308b\u4e73\u623f\u90e8\u7cbe\u67fb\uff08\u8ffd\u52a0\u64ae\u50cf\uff09\u306e\u64ae\u50cf\u30d1\u30e9\u30e1\u30fc\u30bf\u6700\u9069\u5316\uff0e\u7b2c52\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a (2012.10, \u672d\u5e4c)<\/li>\n<li>\u897f\u5ddd\u6566\uff0c\u4e2d\u5cf6\u76f4\u7f8e\uff0c\u7247\u5ca1\u6b63\u660e\uff0c\u5f53\u9662\u306b\u304a\u3051\u308b\u98df\u9053\u304c\u3093\u5316\u5b66\u653e\u5c04\u7dda\u7642\u6cd5\u306e\u6cbb\u7642\u6210\u7e3e\u3000\u7b2c25\u56de\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\uff082012, 11\u6771\u4eac\uff09<\/li>\n<li>\u677e\u7530\u5353\u4e5f, \u5bae\u5ddd\u6b63\u7537, \u4e2d\u6751\u58ee\u5fd7, \u897f\u5c71\u9999\u5b50, \u5ddd\u53e3\u76f4\u4eba, \u57ce\u6238\u502b\u4e4b, \u57ce\u6238\u8f1d\u4ec1, \u5009\u7530\u8056, \u671b\u6708\u8f1d\u4e00. \u5fc3\u623f\u7d30\u52d5\u60a3\u8005\u306b\u304a\u3051\u308b\u5fc3\u81d3\u3078\u306eF-18 FDG\u96c6\u7a4d\u306e\u7279\u5fb4.\u3000\u7b2c75\u56de\u65e5\u672c\u5fc3\u81d3\u8840\u7ba1\u653e\u5c04\u7dda\u7814\u7a76\u4f1a\u3000(2012.7, \u6771\u4eac)<\/li>\n<li>\u5bae\u5ddd\u6b63\u7537, \u8d77\u585a\u9999\u5b50, \u5ddd\u53e3\u76f4\u4eba, \u57ce\u6238\u502b\u4e4b, \u57ce\u6238\u8f1d\u4ec1, \u671b\u6708\u8f1d\u4e00. \u5fc3\u30a2\u30df\u30ed\u30a4\u30c9\u30fc\u30b7\u30b9\u306b\u304a\u3051\u308bFDG\u96c6\u7a4d\u306e\u7279\u5fb4\u2014\u30d8\u30d1\u30ea\u30f3\u8ca0\u8377PET\u306b\u3088\u308b\u691c\u8a0e. \u7b2c52\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a(2012.10, \u672d\u5e4c)<\/li>\n<li>\u83ca\u6c60\u9686\u5fb3\uff0c\u4e95\u4e0a\u6b66\uff0c\u6d77\u8001\u539f\u308b\u3044\uff0c\u7a32\u6708\u5343\u5c0b\uff0c\u5c0f\u7530\u5c1a\u543e\uff0c\u77f3\u4e38\u826f\u5e83\uff0c\u677e\u6728\u5f18\u91cf\uff0c\u4e2d\u6751\u8aa0\u6cbb.\u597d\u9178\u7403\u5897\u591a\u6027\u8840\u7ba1\u6d6e\u816b\u306ePET\u6240\u898b. \u7b2c52\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a(2012.10.\u3000\u672d\u5e4c)<\/li>\n<li>\u4e2d\u6751\u8aa0\u6cbb\uff0c\u83ca\u6c60\u9686\u5fb3\uff0c\u6d77\u8001\u539f\u308b\u3044\uff0c\u7a32\u6708\u5343\u5c0b\uff0c\u5c0f\u7530\u5c1a\u543e\uff0c\u77f3\u4e38\u826f\u5e83\uff0c\u677e\u6728\u5f18\u91cf\uff0c\u4e95\u4e0a\u6b66. Split-dose\u6cd5\u3092\u57fa\u306b\u3057\u305f1\u70b9\u9759\u8108\u63a1\u8840\u306b\u3088\u308b\u5c40\u6240\u8133\u8840\u6d41\u91cf\u5b9a\u91cf\u6cd5. \u7b2c52\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a(2012.10.\u3000\u672d\u5e4c)<\/li>\n<li>\u4e95\u4e0a\u6b66\uff0c\u83ca\u6c60\u9686\u5fb3\uff0c\u6d77\u8001\u539f\u308b\u3044\uff0c\u7a32\u6708\u5343\u5c0b\uff0c\u5c0f\u7530\u5c1a\u543e\uff0c\u77f3\u4e38\u826f\u5e83\uff0c\u677e\u6728\u5f18\u91cf\uff0c\u4e2d\u6751\u8aa0\u6cbb.\u3000 FDG-PET\/CT\u3092\u65bd\u884c\u3057\u305f\u814e\u30b5\u30eb\u30b3\u30a4\u30c9\u30fc\u30b7\u30b9\u306e\u4e00\u4f8b. \u7b2c52\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a(2012.10.\u3000\u672d\u5e4c)<\/li>\n<li>\u4e95\u4e0a\u6b66\uff0c\u83ca\u6c60\u9686\u5fb3\uff0c\u6d77\u8001\u539f\u308b\u3044\uff0c\u7a32\u6708\u5343\u5c0b\uff0c\u5c0f\u7530\u5c1a\u543e\uff0c\u77f3\u4e38\u826f\u5e83\uff0c\u677e\u6728\u5f18\u91cf\uff0c\u4e2d\u6751\u8aa0\u6cbb. \u7d50\u6838\u6027\u8179\u819c\u708e\u306ePET-CT\u6240\u898b\u3000-\u304c\u3093\u6027\u8179\u819c\u708e\u3068\u306e\u6bd4\u8f03-. \u7b2c52\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a(2012.10.\u3000\u672d\u5e4c)<\/li>\n<li>\u4e95\u4e0a\u6b66\uff0c\u83ca\u6c60\u9686\u5fb3\uff0c\u6d77\u8001\u539f\u308b\u3044\uff0c\u7a32\u6708\u5343\u5c0b\uff0c\u5c0f\u7530\u5c1a\u543e\uff0c\u77f3\u4e38\u826f\u5e83\uff0c\u677e\u6728\u5f18\u91cf\uff0c\u4e2d\u6751\u8aa0\u6cbb. \u9aa8\u30b7\u30f3\u30c1\u306b\u304a\u3051\u308b\u8907\u96d1\u7cfb\u30e2\u30c7\u30eb\u89e3\u6790\u306e\u691c\u8a0e\u3000-\u81e8\u5e8a\u7de8-.\u7b2c52\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a(2012.10.\u3000\u672d\u5e4c)<\/li>\n<li>\u8d77\u585a\u9999\u5b50, \u5bae\u5ddd\u6b63\u7537,\u4e2d\u6751\u58ee\u5fd7, \u677e\u7530\u5353\u4e5f, \u5ddd\u53e3\u76f4\u4eba, \u57ce\u6238\u502b\u4e4b, \u5009\u7530\u8056, \u57ce\u6238\u8f1d\u4ec1, \u897f\u5c71\u5149,\u9ad8\u6a4b\u5eb7\u5e78, \u671b\u6708\u8f1d\u4e00. \u5fc3\u81d3\u7528\u534a\u5c0e\u4f53SPECT\u3068256\u5217\u51a0\u52d5\u8108CT angiography\u3092\u7528\u3044\u305fSPECT\/CT fusion\u753b\u50cf\u306e\u8a55\u4fa1. \u7b2c52\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a (2012.10, \u672d\u5e4c)<\/li>\n<li>\u8d77\u585a\u9999\u5b50, \u5bae\u5ddd\u6b63\u7537,\u4e2d\u6751\u58ee\u5fd7, \u677e\u7530\u5353\u4e5f, \u5ddd\u53e3\u76f4\u4eba, \u57ce\u6238\u502b\u4e4b, \u57ce\u6238\u8f1d\u4ec1, \u5009\u7530\u8056, \u77f3\u6751\u96bc\u4eba, \u9ad8\u6a4b\u5eb7\u5e78, \u671b\u6708\u8f1d\u4e00. \u534a\u5c0e\u4f53\u691c\u51fa\u5668SPECT\u306b\u3088\u308bSupine-Prone\u50cf\u3092\u7528\u3044\u305f\u5fc3\u7b4b\u865a\u8840\u8a55\u4fa1. \u7b2c52\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a (2012.10, \u672d\u5e4c)<\/li>\n<li>\u5ddd\u53e3\u76f4\u4eba, \u5bae\u5ddd\u6b63\u7537, \u897f\u5c71\u9999\u5b50, \u57ce\u6238\u502b\u4e4b, \u57ce\u6238\u8f1d\u4ec1, \u77f3\u6751\u96bc\u4eba, \u671b\u6708\u8f1d\u4e00. \u534a\u5c0e\u4f53\u691c\u51fa\u5668\u3092\u7528\u3044\u305fI-123 BMIPP\u306e\u30c0\u30a4\u30ca\u30df\u30c3\u30af\u53ce\u96c6\u3068\u4e8c\u6838\u7a2e\u540c\u6642\u53ce\u96c6\u306e\u8a55\u4fa1. \u7b2c52\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a (2012.10, \u672d\u5e4c)<\/li>\n<li>\u6700\u4e0a\u535a\uff0c\u83c5\u539f\u793c\u5b50\uff0c\u5ddd\u4e0a\u58fd\u662d\uff0c\u305d\u306e\u4ed6\uff0e\u7e70\u308a\u8fd4\u3057\u53d7\u8a3a\u8005\u306e\u75c5\u671f\u3068\u524d\u56de\u6240\u898b\uff0e\u7b2c22\u56de\u65e5\u672c\u4e73\u764c\u691c\u8a3a\u5b66\u4f1a\u7dcf\u4f1a\uff082012.11\uff0c\u5b9c\u91ce\u6e7e\uff09<\/li>\n<\/ol>\n<p><a id=\"07\"><\/a><span style=\"color: #d391a8;\">\u25cf<\/span> \u56fd\u5185\u5b66\u4f1a\uff08\u5730\u65b9\u4f1a\uff09<\/p>\n<p>\u56fd\u5185\u5b66\u4f1a\uff08\u5730\u65b9\u4f1a\uff09<\/p>\n<ol>\n<li>\u5175\u982d\u670b\u5b50, \u5ca1\u7530\u771f\u5e83, \u9999\u5ddd\u7950\u6bc5, \u65e5\u9ad8\u6b63\u4e8c\u6717, \u67f3\u751f\u884c\u4f38, \u4e0a\u5d8b\u4e00\u81e3, \u77e2\u7530\u5178\u4e45, \u677e\u6728\u5145, \u8db3\u5229\u7adc\u4e00\u6717, \u77f3\u4e95\u4e00\u6210, \u5de5\u85e4\u6b63\u4fca, \u6751\u4e0a\u5353\u9053. CT perfusion\u306b\u3088\u308b\u809d\u8840\u884c\u52d5\u614b\u89e3\u6790\uff1asorafenib\u6295\u4e0e\u306b\u3088\u308b\u80cc\u666f\u809d\u8840\u6d41\u306e\u5909\u5316\u3068\u809d\u7d30\u80de\u764c\u6cbb\u7642\u52b9\u679c. \u7b2c12\u56de\u95a2\u897f\u809d\u8840\u6d41\u52d5\u614b\u30a4\u30e1\u30fc\u30b8\u7814\u7a76\u4f1a (2012.6, \u5927\u962a)<\/li>\n<li>\u897f\u5ddd\u6566\uff0c\u8d8a\u667a\u8a89\u53f8\uff0c\u4e2d\u5cf6\u76f4\u7f8e\uff0c\u7247\u5ca1\u6b63\u660e \u5f53\u9662\u306b\u304a\u3051\u308b\u98df\u9053\u764c\u6839\u6cbb\u7684\u5316\u5b66\u653e\u5c04\u7dda\u7642\u6cd5\u306e\u6cbb\u7642\u6210\u7e3e\uff0e\u7b2c118\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\u3000(2012, 6\uff0c\u5ca1\u5c71)<\/li>\n<li>\u7d30\u5ddd\u6d69\u5e73, \u7530\u908a\u88d5\u8cb4, \u68b6\u539f\u3000\u8aa0, \u6e05\u6c34\u8f1d\u5f66, \u9ad8\u6a4b\u5fe0\u7ae0, \u9152\u4e95\u4f38\u4e5f, \u83c5\u539f\u656c\u6587, \u5927\u7530\u8015\u53f8, \u68da\u7530\u3000\u7a14, \u9ad8\u7551\u6d69\u4e4b\uff0e\u814e\u7d30\u80de\u764c\u80c6\u56a2\u8ee2\u79fb\u306e\uff11\u4f8b\uff0e\u7b2c118\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\uff082012.6\u3000\u5ca1\u5c71\uff09<\/li>\n<li>\u7a32\u6708\u5343\u5c0b\uff0c\u4e09\u6728\u5747\uff0c\u5c0f\u7530\u5c1a\u543e\uff0c\u66fd\u6211\u90e8\u4e00\u90ce\uff0c\u83ca\u6c60\u9686\u5fb3\uff0c\u5e73\u585a\u7fa9\u5eb7\uff0c\u83ca\u6c60\u6075\u4e00\uff0c\u671b\u6708\u8f1d\u4e00\uff0c\u6850\u5c71\u90c1\u5b50.\u982d\u90e8CT\u306b\u304a\u3051\u308b\u9010\u6b21\u8fd1\u4f3c\u6cd5\u306e\u521d\u671f\u4f7f\u7528\u7d4c\u9a13. \u7b2c118\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u56db\u56fd\u5730\u65b9\u4f1a(2012.6. \u5ca1\u5c71)<\/li>\n<li>\u4e09\u597d\u5fb9\uff0c\u4e95\u4e0a\u6b66\uff0c\u5c71\u5d0e\u6d69\u5b9f\uff0c\u7a32\u6708\u5343\u5c0b\uff0c\u6751\u4e0a\u5fe0\u53f8\uff0c\u66fd\u6211\u90e8\u4e00\u90ce\uff0c\u77f3\u4e38\u826f\u5f18\uff0c\u83ca\u6c60\u9686\u5fb3\uff0c\u4e2d\u6751\u8aa0\u6cbb\uff0c\u4e09\u6728\u5747. \u5076\u7136\u767a\u898b\u3055\u308c\u305f\u4e0a\u90e8\u5c3f\u7ba1\u5468\u56f2\u816b\u760d\u306e\u4e00\u4f8b. \u7b2c118\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u56db\u56fd\u5730\u65b9\u4f1a(2012.6. \u5ca1\u5c71)<\/li>\n<li>\u6d77\u8001\u539f\u308b\u3044\uff0c\u6751\u4e0a\u5fe0\u53f8\uff0c\u5c71\u5d0e\u6d69\u5b9f\uff0c\u7a32\u6708\u5343\u5c0b\uff0c\u66fd\u6211\u90e8\u4e00\u90ce\uff0c\u77f3\u4e38\u826f\u5f18\uff0c\u83ca\u6c60\u9686\u5fb3\uff0c\u4e95\u4e0a\u6b66\uff0c\u4e2d\u6751\u8aa0\u6cbb\uff0c\u4e09\u6728\u5747. \u5947\u7570\u306a\u5f62\u614b\u3092\u793a\u3057\u305f\u591a\u767a\u80ba\u816b\u7624\u306e\u4e00\u4f8b. \u7b2c118\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u56db\u56fd\u5730\u65b9\u4f1a(2012.6. \u5ca1\u5c71)<\/li>\n<li>\u7530\u908a\u88d5\u8cb4, \u7d30\u5ddd\u6d69\u5e73, \u68b6\u539f\u3000\u8aa0, \u6e05\u6c34\u8f1d\u5f66, \u9ad8\u6a4b\u5fe0\u7ae0, \u9152\u4e95\u4f38\u4e5f, \u83c5\u539f\u656c\u6587, \u5927\u7530\u8015\u53f8, \u68da\u7530\u3000\u7a14, \u9ad8\u7551\u6d69\u4e4b\uff0e\u81b5\u764c\u3068\u9451\u5225\u304c\u56f0\u96e3\u3067\u3042\u3063\u305f\u81b5\u30ea\u30f3\u30d1\u4e0a\u76ae\u56a2\u80de\u306e\uff11\u4f8b\uff0e\u7b2c118\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\uff082012.6\u3000\u5ca1\u5c71\uff09<\/li>\n<li>\u4e2d\u5cf6\u76f4\u7f8e, \u897f\u5ddd\u3000\u6566, \u8d8a\u667a\u8a89\u53f8, \u7247\u5ca1\u6b63\u660e, \u9ad8\u6a4b\u5fe0\u7ae0, \u9152\u4e95\u4f38\u4e5f, \u83c5\u539f\u656c\u6587\uff0eStage\u2161,\u2162\u4e73\u764c\u8853\u5f8c\u7167\u5c04\u65bd\u884c\u4f8b\u306b\u304a\u3051\u308b\u6cbb\u7642\u524dFDG-PET\/CT\u306b\u3088\u308b\u518d\u767a\u4e88\u6e2c\u306e\u691c\u8a0e\uff0e\u7b2c118\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\uff082012.6\u3000\u5ca1\u5c71\uff09<\/li>\n<li>\u798f\u5c71\u76f4\u7d00, \u5409\u5ca1\u771f\u4e8c, \u795e\u5d0e\u535a\u5145, \u5e73\u7530\u96c5\u662d, \u6d66\u5cf6\u96c4\u4ecb, \u6751\u7530\u7e41\u5229. \u81b5\u306b\u96a3\u63a5\u3057\u305f\u30ea\u30f3\u30d1\u88c5\u7f6e\u306b\u5c40\u5728\u3057\u305f\u6ffe\u80de\u6027\u30ea\u30f3\u30d1\u816b\uff1a\u7a00\u306a1\u4f8b. 118\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a(2012.6, \u5ca1\u5c71)<\/li>\n<li>\u7d30\u5ddd\u6d69\u5e73, \u7530\u908a\u88d5\u8cb4, \u68b6\u539f\u3000\u8aa0, \u6e05\u6c34\u8f1d\u5f66, \u9ad8\u6a4b\u5fe0\u7ae0, \u9152\u4e95\u4f38\u4e5f, \u83c5\u539f\u656c\u6587, \u5927\u4f4f\u7701\u4e09, \u6e05\u85e4\u4f50\u77e5\u5b50, \u897f\u6751\u7406\u6075\u5b50\uff0e\u4e73\u764c\u8853\u524d\u5316\u5b66\u7642\u6cd5\u306eFDG-PET\/CT\u8a55\u4fa1\u3068\u4e88\u5f8c\uff0e\u7b2c47\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\uff082012.6\u3000\u5ca1\u5c71\uff09<\/li>\n<li>\u5c0f\u91ce\u525b\u53f2, \u68ee\u6fa4\u5584\u884c, \u77f3\u4e95\u96c5\u91cf, \u6ff1\u7530\u4f50\u5229, \u9152\u4e95\u4f38\u4e5f, \u83c5\u539f\u656c\u6587\uff0e\u9aa8\u30b7\u30f3\u30c1\u30b0\u30e9\u30d5\u30a3\u8a3a\u65ad\u652f\u63f4\u30bd\u30d5\u30c8BONENAVI\u306e\u521d\u671f\u4f7f\u7528\u7d4c\u9a13\uff0e\u7b2c47\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\uff082012.6\u3000\u5ca1\u5c71\uff09<\/li>\n<li>\u6700\u4e0a\u535a\uff0c\u83c5\u539f\u793c\u5b50\uff0c\u5ddd\u4e0a\u58fd\u662d\uff0c\u305d\u306e\u4ed6\uff0e\u4e73\u764c\u691c\u8a3a\u7e70\u308a\u8fd4\u3057\u53d7\u8a3a\u8005\u306e\u75c5\u671f\u3068\u524d\u56de\u6240\u898b\uff0e\u7b2c15\u56de\u56db\u56fd\u4e73\u623f\u753b\u50cf\u7814\u7a76\u4f1a\uff082012.7\uff0c\u677e\u5c71\uff09<\/li>\n<li>\u798f\u5c71\u76f4\u7d00, \u5409\u5ca1\u771f\u4e8c, \u795e\u5d0e\u535a\u5145, \u5e73\u7530\u96c5\u662d, \u6d66\u5cf6\u96c4\u4ecb, \u6751\u7530\u7e41\u5229. \u81b5SPN\u306e\uff11\u4f8b\uff1a\u81ea\u9a13\u4f8b6\u75c7\u4f8b\u306ereview. 119\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a(2012.12, \u5ca1\u5c71)<\/li>\n<li>\u795e\u5d0e\u535a\u5145, \u5409\u5ca1\u771f\u4e8c, \u798f\u5c71\u76f4\u7d00, \u5e73\u7530\u96c5\u662d, \u6d66\u5cf6\u7950\u4ecb, \u6751\u7530\u7e41\u5229. MTX\u95a2\u9023\u30ea\u30f3\u30d1\u5897\u6b96\u6027\u75be\u60a3\u306e5\u4f8b. \u7b2c118\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a(2012. 6, \u5ca1\u5c71)<\/li>\n<li>\u795e\u5d0e\u535a\u5145, \u5409\u5ca1\u771f\u4e8c, \u798f\u5c71\u76f4\u7d00, \u5e73\u7530\u96c5\u662d, \u6d66\u5cf6\u7950\u4ecb, \u6751\u7530\u7e41\u5229. MTX\u95a2\u9023\u30ea\u30f3\u30d1\u5897\u6b96\u6027\u75be\u60a3\u306e6\u75c7\u4f8b\u306e\u691c\u8a0e. \u7b2c119\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a(2012. 6, \u5ca1\u5c71)<\/li>\n<li>\u5c0f\u91ce\u525b\u53f2, \u68ee\u6fa4\u5584\u884c, \u77f3\u4e95\u96c5\u91cf, \u6ff1\u7530\u4f50\u5229, \u9152\u4e95\u4f38\u4e5f, \u83c5\u539f\u656c\u6587\uff0e\u9aa8\u30b7\u30f3\u30c1\u30b0\u30e9\u30d5\u30a3\u8a3a\u65ad\u652f\u63f4\u30bd\u30d5\u30c8BONENAVI\u306e\u521d\u671f\u4f7f\u7528\u7d4c\u9a13\uff0e\u7b2c47\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\uff082012.6\u3000\u5ca1\u5c71\uff09<\/li>\n<li>\u6e05\u85e4\u4f50\u77e5\u5b50, \u83c5\u539f\u656c\u6587, \u7d30\u5ddd\u6d69\u5e73, \u9ad8\u6a4b\u4e09\u5948, \u539f\u3000\u6587\u5805, \u9ad8\u7560\u5927\u5178, \u9ad8\u5d8b\u6210\u8f1d, \u9752\u5100\u5065\u4e8c\u90ce, \u5927\u4f4f\u7701\u4e09, \u897f\u6751\u7406\u6075\u5b50\uff0eFDG-PET\/CT\u306b\u3088\u308b\u4e73\u764c\u8853\u524d\u5316\u5b66\u7642\u6cd5\u306e\u52b9\u679c\u5224\u5b9a\u3068\u4e88\u5f8c\u4e88\u6e2c\uff0e\u7b2c\uff19\u56de\u4e73\u764c\u5b66\u4f1a\u4e2d\u56fd\u56db\u56fd\u5730\u65b9\u4f1a\uff082012.9\u3000\u51fa\u96f2\uff09<\/li>\n<li>\u7530\u4e2d\u5b8f\u660e, \u57ce\u6238\u8f1d\u4ec1, \u57ce\u6238\u502b\u4e4b, \u5ddd\u53e3\u76f4\u4eba, \u5e73\u585a\u7fa9\u5eb7, \u671b\u6708\u8f1d\u4e00, \u85e4\u5ca1\u3000\u5fb9, \u5e73\u7530\u96c5\u662d, \u4e09\u6751\u79c0\u6587.Embozene\u7403\u72b6\u585e\u6813\u7269\u8cea\u3092\u4f7f\u7528\u3057\u305f\u5b50\u5bae\u52d5\u9759\u8108\u5947\u5f62\u306e\u4e00\u4f8b. \u7b2c26\u56de\u65e5\u672cIVR\u5b66\u4f1a\u4e2d\u56db\u56fd\u5730\u65b9\u4f1a\uff082012\uff0e10\uff0c\u9ad8\u77e5\uff09<\/li>\n<li>\u5e73\u7530\u96c5\u662d,\u5409\u5ca1\u771f\u4e8c,\u6751\u7530\u7e41\u5229,\u7530\u4e2d\u5b8f\u660e,\u671b\u6708\u8f1d\u4e00. Transdural approach\u306b\u3066CT\u30ac\u30a4\u30c9\u4e0b\u306b\u7a7f\u523a\u5438\u5f15\u3092\u65bd\u884c\u3057\u305f\u690e\u9593\u677f\u56a2\u816b\u306e\u4e00\u4f8b\uff0e\u7b2c26\u56de\u65e5\u672cIVR\u5b66\u4f1a\u4e2d\u56db\u56fd\u5730\u65b9\u4f1a\uff082012\uff0e10\uff0c\u9ad8\u77e5\uff09<\/li>\n<li>\u5e73\u585a\u7fa9\u5eb7\uff0c\u7530\u4e2d\u5b8f\u660e\uff0c\u57ce\u6238\u8f1d\u4ec1\uff0c\u57ce\u6238\u502b\u4e4b\uff0c\u5ddd\u53e3\u76f4\u4eba\uff0c\u671b\u6708\u8f1d\u4e00\uff0c\u4ed6\uff0eSegmental arterial mediolysis(SAM)\u304c\u7591\u308f\u308c\u30b3\u30a4\u30eb\u585e\u6813\u8853\u3092\u65bd\u884c\u3057\u305f1\u4f8b\uff0e\u7b2c26\u56de\u65e5\u672cIVR\u5b66\u4f1a\u4e2d\u56db\u56fd\u5730\u65b9\u4f1a\uff082012\uff0e10\uff0c\u9ad8\u77e5\uff09<\/li>\n<li>\u7a32\u6708\u5343\u5c0b\uff0c\u77f3\u4e38\u826f\u5e83\uff0c\u6751\u4e0a\u5fe0\u53f8\uff0c\u66fd\u6211\u90e8\u4e00\u90ce\uff0c\u4e95\u4e0a\u6b66\uff0c\u4e09\u6728\u5747\uff0c\u7530\u4e2d\u5b8f\u660e. \u591a\u767a\u6027\u56a2\u80de\u814e\u306b\u5bfe\u3059\u308b\u814e\u52d5\u8108\u585e\u6813\u88535\u4f8b\u306e\u7d4c\u9a13. \u7b2c26\u56de\u65e5\u672cIVR\u5b66\u4f1a\u4e2d\u56fd\u56db\u56fd\u5730\u65b9\u4f1a(2012.10. \u9ad8\u77e5)<\/li>\n<li>\u6e05\u6c34\u8f1d\u5f66, \u7530\u908a\u88d5\u8cb4, \u7d30\u5ddd\u6d69\u5e73, \u68b6\u539f\u3000\u8aa0, \u9ad8\u6a4b\u5fe0\u7ae0, \u9152\u4e95\u4f38\u4e5f, \u83c5\u539f\u656c\u6587, \u6e05\u85e4\u4f50\u77e5\u5b50, \u5927\u4f4f\u7701\u4e09, \u897f\u6751\u7406\u6075\u5b50\uff0e\u9020\u5f71MRI\u306b\u3088\u308b\u4e73\u764c\u8853\u524d\u5316\u5b66\u7642\u6cd5\u306e\u6cbb\u7642\u52b9\u679c\u5224\u5b9a\uff0e\u7b2c119\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\uff082012.12\u3000\u5ca1\u5c71\uff09<\/li>\n<li>\u7530\u908a\u88d5\u8cb4, \u7d30\u5ddd\u6d69\u5e73, \u68b6\u539f\u3000\u8aa0, \u6e05\u6c34\u8f1d\u5f66, \u9ad8\u6a4b\u5fe0\u7ae0, \u9152\u4e95\u4f38\u4e5f, \u83c5\u539f\u656c\u6587, \u6d45\u6728\u5f70\u5247, \u7058\u91ce\u6210\u4eba\uff0e\u8a3a\u65ad\u306b\u82e6\u616e\u3057\u305f\u809d\u8840\u7ba1\u8089\u816b\u306e\uff11\u4f8b\uff0e\u7b2c119\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\uff082012.12\u3000\u5ca1\u5c71\uff09<\/li>\n<li>\u897f\u5cf6\u7d00\u5b50\uff0c\u5bae\u5ddd\u6b63\u7537\uff0c\u4e2d\u6751\u58ee\u5fd7\uff0c\u677e\u7530\u5353\u4e5f\uff0c\u8d77\u585a\u9999\u5b50, \u5ddd\u53e3\u76f4\u4eba\uff0c\u57ce\u6238\u502b\u4e4b\uff0c\u57ce\u6238\u8f1d\u4ec1\uff0c\u5009\u7530 \u8056\uff0c\u671b\u6708\u8f1d\u4e00. PET\/CT\u3092\u65bd\u884c\u3057\u305f\u5fc3\u30a2\u30df\u30ed\u30a4\u30c9\u30fc\u30b7\u30b9\u306e\uff13\u4f8b. \u7b2c47\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a \u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a (2012. 6, \u5ca1\u5c71)<\/li>\n<li>\u6797 \u82b1\u6797\uff0c\u6a2a\u5c71\u3089\u307f\uff0c\u5ddd\u53e3\u76f4\u4eba\uff0c\u4e2d\u6751\u58ee\u5fd7\uff0c\u677e\u7530\u5353\u4e5f\uff0c\u897f\u5c71\u9999\u5b50\uff0c\u57ce\u6238\u502b\u4e4b\uff0c\u57ce\u6238\u8f1d\u4ec1\uff0c\u5bae\u5ddd\u6b63\u7537\uff0c\u671b\u6708\u8f1d\u4e00. FDG-PET\/CT \u306b\u3066\u7d4c\u904e\u89b3\u5bdf\u3055\u308c\u305f\u5fc3\u30b5\u30eb\u30b3\u30a4\u30c9\u30fc\u30b7\u30b9\u306e3 \u4f8b. \u7b2c119 \u56de \u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a (2012.12, \u5ca1\u5c71)<\/li>\n<li>\u6d77\u8001\u539f\u308b\u3044\uff0c\u4e95\u4e0a\u6b66\uff0c\u6751\u4e0a\u5fe0\u53f8\uff0c\u4e09\u597d\u5fb9\uff0c\u5c71\u5d0e\u6d69\u5b9f\uff0c\u7a32\u6708\u5343\u5c0b\uff0c\u5c0f\u7530\u5c1a\u543e\uff0c\u66fd\u6211\u90e8\u4e00\u90ce\uff0c\u77f3\u4e38\u826f\u5f18\uff0c\u83ca\u6c60\u9686\u5fb3\uff0c\u4e2d\u6751\u8aa0\u6cbb\uff0c\u4e09\u6728\u5747. \u5076\u7136\u767a\u898b\u3055\u308c\u305f\u591a\u767a\u809d\u816b\u7624\u306e\u4e00\u4f8b. \u7b2c119\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u56db\u56fd\u5730\u65b9\u4f1a(2012.12. \u5ca1\u5c71)<\/li>\n<li>\u897f\u5ddd \u6566\uff0c\u4e2d\u5cf6\u76f4\u7f8e\uff0c\u7247\u5ca1\u6b63\u660e\u3000\u98df\u9053\u764c\u8853\u5f8c\u518d\u767a\u306b\u5bfe\u3059\u308b\u653e\u5c04\u7dda\u6cbb\u7642\u7d4c\u9a13\uff0e\u7b2c61\u56de\u4e2d\u56fd\u30fb\u56db\u56fd\u653e\u5c04\u7dda\u6cbb\u7642\u61c7\u8a71\u4f1a\uff082012, 12, \u5ca1\u5c71\uff09<\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<p><a id=\"08\"><\/a><strong><span style=\"color: #336699;\">\u25a0<\/span> \u8b1b\u6f14<\/strong><\/p>\n<ol>\n<li>\u5c71\u672c\u5c1a\u5e78\uff0e\u653e\u5c04\u7dda\u95a2\u9023\u4e8b\u6545\u3068\u4fdd\u5065\u6240\u306e\u5bfe\u5fdc. \u5927\u962a\u5730\u533a\u7dca\u6025\u88ab\u3070\u304f\u533b\u7642\u300c\u4fdd\u5065\u6240\u7b49\u95a2\u4fc2\u8005\u7814\u4fee\u4f1a\u300d\uff082012.2\uff0c\u5927\u962a\uff09<\/li>\n<li>\u5c71\u672c\u5c1a\u5e78. \u7dca\u6025\u88ab\u3070\u304f\u533b\u7642\u306b\u3064\u3044\u3066. \u611b\u5a9b\u653e\u5c04\u7dda\u7ba1\u7406\u58eb\u90e8\u4f1a\u7814\u4fee\u4f1a\uff082012.2\uff0c\u677e\u5c71\uff09<\/li>\n<li>\u5c71\u672c\u5c1a\u5e78. \u7dca\u6025\u88ab\u3070\u304f\u533b\u7642\u306e\u57fa\u790e\u77e5\u8b58\uff5e\u8a3a\u7642\u653e\u5c04\u7dda\u6280\u5e2b\u306b\u6c42\u3081\u3089\u308c\u308b\u3053\u3068\uff5e\uff0e\u3072\u3046\u3061\u6838\u533b\u5b66\u30bb\u30df\u30ca\u30fc\uff082012.\uff17\uff0c\u677e\u5c71\uff09<\/li>\n<li>\u5c71\u672c\u5c1a\u5e78\uff0e\u5b50\u4f9b\u3092\u5b88\u308b\u305f\u3081\u306e\u653e\u5c04\u7dda\u88ab\u3070\u304f\u5bfe\u7b56\u3068\u5bfe\u5fdc\uff0e\u5e73\u621024\u5e74\u5ea6\u5150\u7ae5\u751f\u5f92\u7b49\u653e\u5c04\u7dda\u88ab\u3070\u304f\u9632\u8b77\u5bfe\u7b56\u7814\u4fee\u4f1a\uff082012.8, \u897f\u4e88\uff09<\/li>\n<li>\u5c71\u672c\u5c1a\u5e78\uff0e\u653e\u5c04\u7dda\u306e\u57fa\u790e\u77e5\u8b58\uff5e\u7279\u306b\u5b66\u6821\u306b\u304a\u3044\u3066\u91cd\u8981\u306a\u3053\u3068\u304c\u3089\u306b\u3064\u3044\u3066\uff5e\uff0e\u5e73\u621024\u5e74\u5ea6\u4e2d\u4e88\u5730\u533a\u5150\u7ae5\u751f\u5f92\u7b49\u653e\u5c04\u7dda\u88ab\u3070\u304f\u9632\u8b77\u5bfe\u7b56\u7814\u4fee\u4f1a\uff082012.8, \u677e\u5c71\uff09<\/li>\n<li>\u5c71\u672c\u5c1a\u5e78\uff0e\u6771\u65e5\u672c\u5927\u5730\u9707\u306b\u307f\u308b\u653e\u5c04\u7dda\u707d\u5bb3\u306e\u5b9f\u614b\u3068\u8a3a\u7642\u653e\u5c04\u7dda\u6280\u5e2b\u3078\u306e\u671f\u5f85\uff0e\u4e5d\u5dde\u5730\u57df\u653e\u5c04\u7dda\u6280\u5e2b\u7814\u4fee\u4f1a\uff082012.9\uff0c\u718a\u672c\uff09<\/li>\n<li>\u5c71\u672c\u5c1a\u5e78\uff0e\u653e\u5c04\u7dda\u306e\u57fa\u790e\u77e5\u8b58\uff5e\u7279\u306b\u5b66\u6821\u306b\u304a\u3044\u3066\u91cd\u8981\u306a\u3053\u3068\u304c\u3089\u306b\u3064\u3044\u3066\uff5e\uff0e\u5e73\u621024\u5e74\u5ea6\u5357\u4e88\u5730\u533a\u5150\u7ae5\u751f\u5f92\u7b49\u653e\u5c04\u7dda\u88ab\u3070\u304f\u9632\u8b77\u5bfe\u7b56\u7814\u4fee\u4f1a\uff082012.9, \u897f\u4e88\uff09<\/li>\n<li>\u5c71\u672c\u5c1a\u5e78\uff0e\u653e\u5c04\u7dda\u306e\u57fa\u790e\u77e5\u8b58\uff5e\u7279\u306b\u5b66\u6821\u306b\u304a\u3044\u3066\u91cd\u8981\u306a\u3053\u3068\u304c\u3089\u306b\u3064\u3044\u3066\uff5e\uff0e\u5e73\u621024\u5e74\u5ea6\u6771\u4e88\u5730\u533a\u5150\u7ae5\u751f\u5f92\u7b49\u653e\u5c04\u7dda\u88ab\u3070\u304f\u9632\u8b77\u5bfe\u7b56\u7814\u4fee\u4f1a\uff082012.9, \u65b0\u5c45\u6d5c\uff09<\/li>\n<li>\u5c71\u672c\u5c1a\u5e78. \u798f\u5cf6\u7b2c\u4e00\u539f\u5b50\u529b\u767a\u96fb\u6240\u4e8b\u6545\u5f8c\u306e\u88ab\u3070\u304f\u533b\u7642\uff5e\u7279\u306b\u653e\u5c04\u7dda\u5c02\u9580\u5bb6\u306e\u5f79\u5272\u306b\u3064\u3044\u3066\uff5e. \u5e73\u621024\u5e74\u5ea6\u653e\u5c04\u7dda\u5b89\u5168\u53d6\u6271\u90e8\u4f1a\u5e74\u6b21\u5927\u4f1a\uff082012.11\uff0c\u677e\u5c71\uff09<\/li>\n<li>\u5c71\u672c\u5c1a\u5e78\uff0e\uff08\u516c\u8ca1\uff09\u539f\u5b50\u529b\u5b89\u5168\u7814\u7a76\u5354\u4f1a\u3067\u306e\u7814\u4fee\u4e8b\u696d\u306b\u3066\u8b1b\u6f14\uff0853\u56de\uff09<\/li>\n<li>\u6771\u91ce\u535a. \u6559\u80b2\u8b1b\u6f1419 \u6838\u533b\u5b662 \u5fc3\u81d3\u6838\u533b\u5b66 CT\u3068\u306e\u6bd4\u8f03\u3092\u4e2d\u5fc3\u306b. \u7b2c71\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a. (2012.4, \u6a2a\u6d5c)<\/li>\n<li>\u6771\u91ce\u535a. \u5fc3 \u5fc3\u7b4b\u8840\u6d41\u30fbperfusion CT. \u7b2c2\u56deAdvanced CT\u30fbMR\u7814\u7a76\u4f1a. (2012.6, \u8efd\u4e95\u6ca2).<\/li>\n<li>\u6771\u91ce\u535a. \u30e9\u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc \u307f\u3093\u306a\u306b\u3084\u3055\u3057\u3044\u5fc3\u81d3\u6838\u533b\u5b66. \u7b2c52\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a. (2012.10, \u672d\u5e4c)<\/li>\n<li>\u6771\u91ce\u535a. \u4f1a\u9577\u8981\u671b\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0 \u51a0\u52d5\u8108\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u306e\u672a\u6765\u3068\u878d\u5408 \u305d\u308c\u305e\u308c\u306e\u679c\u305f\u3059\u5f79\u5272\u3068\u4ed6\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u3078\u306e\u671f\u5f85\u3068\u30e1\u30c3\u30bb\u30fc\u30b8 1. CT, MR\u304b\u3089. \u7b2c26\u56de\u65e5\u672c\u5fc3\u81d3\u8840\u7ba1\u5185\u8996\u93e1\u5b66\u4f1a. (2012.10, \u677e\u5c71)<\/li>\n<li>\u5bae\u5ddd\u6b63\u7537. \u65b0\u3057\u3044\u5fc3\u81d3\u5c02\u7528\u534a\u5c0e\u4f53SPECT: Discovery NM530c\u306b\u3064\u3044\u3066. \u7b2c50\u56de\u3000\u5c71\u967d\u6838\u533b\u5b66\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9\u6307\u540d\u8b1b\u6f14 \uff082012.5\uff0c\u5ca1\u5c71\uff09<\/li>\n<li>\u5bae\u5ddd\u6b63\u7537, \u77f3\u6751\u96bc\u4eba, \u8d77\u585a\u9999\u5b50, \u5ddd\u53e3\u76f4\u4eba, \u57ce\u6238\u502b\u4e4b, \u57ce\u6238\u8f1d\u4ec1, \u5009\u7530\u8056, \u671b\u6708\u8f1d\u4e00. \u534a\u5c0e\u4f53SPECT\u306e\u5fc3\u81d3\u6838\u533b\u5b66\u3078\u306e\u30a4\u30f3\u30d1\u30af\u30c8\uff1a\u7a7a\u9593\u5206\u89e3\u80fd\u3001\u30a8\u30cd\u30eb\u30ae\u30fc\u5206\u89e3\u80fd\u306e\u5411\u4e0a\u53ca\u3073\u5fc3\u7b4b\u8840\u6d41\u5b9a\u91cf\u8a55\u4fa1\u306b\u3064\u3044\u3066\u3000\u7b2c22\u56de\u3000\u65e5\u672c\u5fc3\u81d3\u6838\u533b\u5b66\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0 (2012.6, \u91d1\u6ca2)<\/li>\n<li>\u5bae\u5ddd\u6b63\u7537. \u5fc3\u81d3\u6838\u533b\u5b66\u306b\u304a\u3051\u308b\u534a\u5c0e\u4f53SPECT\u306e\u5f79\u5272. \u7b2c58\u56de\u3000\u5317\u9678\u5faa\u74b0\u5668\u6838\u533b\u5b66\u7814\u7a76\u4f1a\u7279\u5225\u8b1b\u6f14 (2012.7, \u91d1\u6ca2)<\/li>\n<li>\u5bae\u5ddd\u6b63\u7537. \u5fc3\u7b4b\u708e\u75c7\u75c5\u5909\u306e\u691c\u51fa\uff1a\u9577\u671f\u7d76\u98df\u304a\u3088\u3073\u30d8\u30d1\u30ea\u30f3\u8ca0\u8377\u306b\u3064\u3044\u3066. PET\u30b5\u30de\u30fc\u30bb\u30df\u30ca\u30fc2012 in \u4fe1\u5dde\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff082012.8\uff0c\u677e\u672c\uff09<\/li>\n<li>\u5bae\u5ddd\u6b63\u7537. \u653e\u5c04\u7dda\u3068\u7532\u72b6\u817a. \u5185\u5206\u6ccc\u5b66\u4f1a\u5e02\u6c11\u516c\u958b\u8b1b\u5ea7 \u7b2c22\u56de\u3000\u30d8\u30eb\u30b9\u30a2\u30ab\u30c7\u30df\u30fc\uff082012.9\uff0c\u677e\u5c71\uff09<\/li>\n<li>\u5bae\u5ddd\u6b63\u7537. \u4fdd\u967a\u9069\u5fdc\u62e1\u5927\u4ee5\u964d\u306ePET\/CT\u306e\u52d5\u5411. \u7b2c14\u56de\u3000\u4eca\u6cbb\u5730\u57df\u304c\u3093\u8a3a\u7642\u30d5\u30a9\u30fc\u30e9\u30e0\uff082012.10\uff0c\u4eca\u6cbb\uff09<\/li>\n<li>\u5bae\u5ddd\u6b63\u7537.\u3000\u534a\u5c0e\u4f53\u30ab\u30e1\u30e9Discovery\u306e\u6700\u65b0\u60c5\u5831.\u3000\u7b2c28\u56de\u3000\u611b\u5a9b\u5fc3\u81d3\u6838\u533b\u5b66\u8ac7\u8a71\u4f1a\u6307\u540d\u8b1b\u6f14\uff082012.10\uff0c\u677e\u5c71\uff09<\/li>\n<li>\u5bae\u5ddd\u6b63\u7537. \u4fdd\u967a\u9069\u5fdc\u62e1\u5927\u4ee5\u964d\u306ePET\/CT\u306e\u52d5\u5411. \u7b2c48\u56de \u9020\u5f71\u7814\u7a76\u4f1a\uff082012.12\uff0c\u4eca\u6cbb\uff09<\/li>\n<li>\u6d25\u7530\u5b5d\u6cbb.\u75c7\u4f8b\u304b\u3089\u5b66\u3076\u81b5\u764c\u306e\u65e9\u671f\u8a3a\u65ad\u3078\u306e\u624b\u304c\u304b\u308a\u3000\u7b2c6\u56de\u611b\u5a9b\u6d88\u5316\u7ba1\u8d85\u97f3\u6ce2\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9\uff082012.1\uff0c\u677e\u5c71\uff09<\/li>\n<li>\u6d25\u7530\u5b5d\u6cbb.\u5927\u8178\u764c\u306e\u8853\u524d\u652f\u63f4\u8a3a\u65ad\u3068CT colonography\u306e\u53d6\u308a\u7d44\u307f\u3000CT\u30fbMRI\u7814\u7a76\u4f1a\u611b\u5a9b\uff082012.1\uff0c\u677e\u5c71\uff09<\/li>\n<li>\u4e95\u4e0a\u6b66. PET-CT\u3067\u304c\u3093\u306f\u3069\u3053\u307e\u3067\u308f\u304b\u308b\u306e\u304b\uff1f\u611b\u5a9b\u770c\u7acb\u4e2d\u592e\u75c5\u9662\u4e3b\u50ac\u3000\u5e02\u6c11\u516c\u958b\u8b1b\u5ea7(2012.2.\u677e\u5c71)<\/li>\n<li>\u4e09\u6728\u3000\u5747. \u75c7\u4f8b\u63d0\u793a1. \u7b2c34\u56deNeuroradiology Club(2012.6.\u6771\u4eac)<\/li>\n<li>\u4e95\u4e0a\u6b66. \u4e73\u304c\u3093\u306eFDG-PET\/CT. \u7b2c48\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a \u6559\u80b2\u8b1b\u6f14\u300e\u6838\u533b\u5b66\u300f (2012.9.\u9577\u5d0e)<\/li>\n<li>\u4e95\u4e0a\u6b66. \u611b\u5a9b\u770c\u9662\u5185\u304c\u3093\u767b\u9332\u5b9f\u52d9\u8005\u7814\u4fee\u4f1a\u300c\u809d\u81d3\u304c\u3093\u306eTNM\u5206\u985e\u306b\u3064\u3044\u3066\u300d\u3000\uff082012.9.\u56db\u56fd\u304c\u3093\u30bb\u30f3\u30bf\u30fc\uff09<\/li>\n<li>\u4e95\u4e0a\u6b66. \u611b\u5a9b\u770c\u9662\u5185\u304c\u3093\u767b\u9332\u5b9f\u52d9\u8005\u7814\u4fee\u4f1a\u300c\u80ba\u304c\u3093\u306eTNM\u5206\u985e\u306b\u3064\u3044\u3066\u300d\uff082012.10.\u56db\u56fd\u304c\u3093\u30bb\u30f3\u30bf\u30fc\uff09<\/li>\n<li>\u4e95\u4e0a\u6b66. \u611b\u5a9b\u770c\u9662\u5185\u304c\u3093\u767b\u9332\u5b9f\u52d9\u8005\u7814\u4fee\u4f1a\u300c\u4e73\u304c\u3093\u306eTNM\u5206\u985e\u306b\u3064\u3044\u3066\u300d\uff082012.11.\u56db\u56fd\u304c\u3093\u30bb\u30f3\u30bf\u30fc\uff09<\/li>\n<li>\u6700\u4e0a\u535a\uff0e\u4e73\u764c\u691c\u8a3a\u306b\u3064\u3044\u3066\uff0e\u611b\u5a9b\u770c\u4e73\u764c\u691c\u8a3a\u5f93\u4e8b\u8005\u8b1b\u7fd2\u4f1a\uff082012.2\uff0c\u677e\u5c71\uff09<\/li>\n<li>\u7530\u4e2d\u5b8f\u660e.\u30c7\u30bf\u30c3\u30c1\u30e3\u30d6\u30eb\u30b3\u30a4\u30eb\u3092\u4f7f\u7528\u3057\u305f\u585e\u6813\u8853\u306b\u3064\u3044\u3066\u306e\u57fa\u672c\u4e8b\u9805\u3068\u5b9f\u969b.\u7b2c26\u56de\u65e5\u672cIVR\u5b66\u4f1a\u4e2d\u56fd\u56db\u56fd\u5730\u65b9\u4f1a(2012.10,\u9ad8\u77e5)<\/li>\n<li>\u57ce\u6238 \u8f1d\u4ec1\uff0e\u30e9\u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc\u300cDSCT\u3092\u7528\u3044\u305f\u5fc3\u7b4b\u865a\u8840\u3068\u6027\u72b6\u8a55\u4fa1\u306e\u8a66\u307f\u300d\uff0e\u65e5\u672c\u5fc3\u8840\u7ba1\u653e\u5c04\u7dda\u7814\u7a76\u4f1a\uff082012.1\u540d\u53e4\u5c4b\uff09<\/li>\n<li>\u57ce\u6238 \u8f1d\u4ec1\uff0e\u30ef\u30fc\u30af\u30bb\u30c3\u30b7\u30e7\u30f3\u300c\u51a0\u52d5\u8108CT\u306e\u753b\u50cf\u51e6\u7406\u3068\u8aad\u5f71\u306e\u5b9f\u969b\uff1bCT\u3092\u7528\u3044\u305f\u51a0\u52d5\u8108\u8a55\u4fa1\u306e\u73fe\u72b6\u3068\u5c55\u671b\u300d\uff0e\u65e5\u672c\u5fc3\u8840\u7ba1\u753b\u50cf\u52d5\u614b\u5b66\u4f1a\uff082012.1.\u540d\u53e4\u5c4b\uff09<\/li>\n<li>\u57ce\u6238 \u8f1d\u4ec1\uff0e\u5fc3\u81d3CT\u30ec\u30af\u30c1\u30e3\u30fc\u300c\u5fc3\u81d3CT\u306e\u73fe\u72b6\u300d\uff0e\u677e\u5c71\u9053\u5f8cLIVE2012\uff082012.1.\u677e\u5c71\uff09<\/li>\n<li>\u57ce\u6238 \u8f1d\u4ec1\uff0e\u300c\u5fc3\u81d3CT\u306e\u65b0\u3057\u3044\u6d41\u308c\uff1b\u51a0\u52d5\u8108\u72ed\u7a84\u8a55\u4fa1\u306e\u6b21\u306f\u30d7\u30e9\u30fc\u30af\u8a55\u4fa1\uff1f\u5fc3\u7b4b\u865a\u8840\u8a55\u4fa1\uff1f\u300d\uff0e\u7b2c31\u56de\u65e5\u672c\u753b\u50cf\u533b\u5b66\u4f1a\uff082012.2.\u6771\u4eac\uff09<\/li>\n<li>\u57ce\u6238 \u8f1d\u4ec1\uff0e\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300c\u3053\u308c\u304b\u3089\u306e\u5de6\u5ba4\u306e\u8a71\u3092\u3057\u3088\u3046\u2212\u5404\u7a2e\u30e2\u30c0\u30ea\u30c6\u30a3\u306b\u3088\u308b\u5de6\u5ba4\u8a55\u4fa1\u306e\u5b9f\u969b\uff1bCT\u300d\uff0e\u7b2c16\u56de\u6771\u5317\u5fc3\u8840\u7ba1\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u7814\u7a76\u4f1a\uff082012.3.\u4ed9\u53f0\uff09<\/li>\n<li>\u57ce\u6238 \u8f1d\u4ec1\uff0e\u30e9\u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc\u300cCT Coronary Angiography\u306e\u73fe\u72b6\u3068\u8ab2\u984c\u300d\uff0e\u7b2c71\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\uff082012.4.\u30d1\u30b7\u30d5\u30a3\u30b3\u6a2a\u6d5c\uff09<\/li>\n<li>\u57ce\u6238 \u8f1d\u4ec1\uff0e\u300c\u5fc3\u81d3CT\uff1b\u66f4\u306a\u308b\u4f4e\u4fb5\u8972\u691c\u67fb\u3068\u8a3a\u65ad\u7cbe\u5ea6\u5411\u4e0a\u3092\u76ee\u6307\u3057\u3066\u300d\uff0e\u5fb3\u5cf6\u81e8\u5e8a\u30ab\u30f3\u30d5\u30a1\u30e9\u30f3\u30b9\uff082012.8.\u5fb3\u5cf6\uff09<\/li>\n<li>\u57ce\u6238 \u8f1d\u4ec1\uff0e\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300cCT\u306b\u3088\u308b\u865a\u8840\u6027\u5fc3\u75be\u60a3\u306e\u8a55\u4fa1\u300d\uff0e\u611b\u5a9b\u5fc3\u81d3\u6838\u533b\u5b66\u61c7\u8a71\u4f1a\uff082012.10.\u677e\u5c71\uff09<\/li>\n<li>\u57ce\u6238 \u8f1d\u4ec1\uff0eJapanese College of Angiology Award\u300cDual Source CT\u3092\u7528\u3044\u305fDual Energy Imaging\u306b\u3088\u308b\u865a\u8840\u6027\u5fc3\u75be\u60a3\u306e\u8a3a\u65ad\u300d\uff0e\u7b2c53\u56de\u65e5\u672c\u8108\u7ba1\u5b66\u4f1a\u7dcf\u4f1a\uff082012.10.\u6771\u4eac\uff09<\/li>\n<li>\u57ce\u6238 \u8f1d\u4ec1\uff0e\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300c\u51a0\u52d5\u8108\u75be\u60a3\u306b\u304a\u3051\u308b\u865a\u8840\u306e\u6a5f\u80fd\u8a55\u4fa1\u300d\uff0e\u7b2c26\u56de\u65e5\u672c\u5fc3\u81d3\u8840\u7ba1\u5185\u8996\u93e1\u5b66\u4f1a\u7dcf\u4f1a\uff082012.10.\u677e\u5c71\uff09<\/li>\n<li>\u57ce\u6238 \u8f1d\u4ec1\uff0e\u300c\u30bc\u30ed\u304b\u3089\u59cb\u3081\u308b\u5fc3\u7b4b\u753b\u50cf\u8a3a\u65ad\u2212\u30de\u30eb\u30c1\u30e2\u30c0\u30ea\u30c6\u30a3\u6642\u4ee3\u306e\u5e55\u958b\u3051\u2212\u300d\uff0e\u7b2c41\u56de\u65ad\u5c64\u6620\u50cf\u7814\u7a76\u4f1a\uff082012.10.\u5e83\u5cf6\uff09<\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<p><a id=\"09\"><\/a><strong><span style=\"color: #336699;\">\u25a0<\/span> \u7814\u7a76\u52a9\u6210<\/strong><\/p>\n<ol>\n<ol>\n<li>\u6587\u90e8\u79d1\u5b66\u7701\u79d1\u5b66\u7814\u7a76\u8cbb\u88dc\u52a9\u91d1\u30002012\u5e744\u67081\u65e5\uff5e2016\u5e743\u670831\u65e5\uff08\u4e88\u5b9a\uff09\u82e5\u624b\u7814\u7a76 (B) \u8ab2\u984c\u756a\u53f740403836\u3000\u5175\u982d\u670b\u5b50\uff0e\u809d\u306e\u9020\u5f71\u591a\u6642\u76f8CT\u691c\u67fb\u306b\u304a\u3051\u308b\u533b\u7642\u88ab\u3070\u304f\u7dda\u91cf\u3068\u9020\u5f71\u5264\u91cf\u306e\u6700\u9069\u5316<\/li>\n<\/ol>\n<\/ol>\n<p><a id=\"10\"><\/a><strong><span style=\"color: #336699;\">\u25a0<\/span> \u53d7\u8cde<\/strong><\/p>\n<p>1.\u6700\u512a\u79c0\u6f14\u984c\u8cde<\/p>\n<p>\u5175\u982d\u670b\u5b50, \u5ca1\u7530\u771f\u5e83, \u9999\u5ddd\u7950\u6bc5, \u65e5\u9ad8\u6b63\u4e8c\u6717, \u67f3\u751f\u884c\u4f38, \u4e0a\u5d8b\u4e00\u81e3, \u77e2\u7530\u5178\u4e45, \u677e\u6728\u5145, \u8db3\u5229\u7adc\u4e00\u6717, \u77f3\u4e95\u4e00\u6210, \u5de5\u85e4\u6b63\u4fca, \u6751\u4e0a\u5353\u9053. CT perfusion\u306b\u3088\u308b\u809d\u8840\u884c\u52d5\u614b\u89e3\u6790\uff1asorafenib\u6295\u4e0e\u306b\u3088\u308b\u80cc\u666f\u809d\u8840\u6d41\u306e\u5909\u5316\u3068\u809d\u7d30\u80de\u764c\u6cbb\u7642\u52b9\u679c. \u7b2c12\u56de\u95a2\u897f\u809d\u8840\u6d41\u52d5\u614b\u30a4\u30e1\u30fc\u30b8\u7814\u7a76\u4f1a (2012.6, \u5927\u962a)<\/p>\n<p>2.\u7389\u85fb\u8cde\uff08\u7b2c47\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\uff082012.6\u3000\u5ca1\u5c71\uff09\u306b\u3066\u8868\u5f70\uff09<\/p>\n<p>\u53d7\u8cde\u5bfe\u8c61\u306f\u6628\u5e74\u767a\u8868\u306e\u4e0b\u8a18\u6f14\u984c<\/p>\n<p>\u7d30\u5ddd\u6d69\u5e73, \u68b6\u539f\u3000\u8aa0, \u6e05\u6c34\u8f1d\u5f66, \u9ad8\u6a4b\u5fe0\u7ae0, \u9152\u4e95\u4f38\u4e5f, \u83c5\u539f\u656c\u6587, \u9752\u5100\u5065\u4e8c\u90ce, \u5927\u4f4f\u7701\u4e09, \u897f\u6751\u7406\u6075\u5b50\uff0eFDG-PET\/CT\u306b\u3088\u308b\u4e73\u764c\u8853\u524d\u5316\u5b66\u7642\u6cd5\u306e\u52b9\u679c\u5224\u5b9a\uff0e\u7b2c46\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\uff082011.5\u3000\u5e83\u5cf6\uff09<\/p>\n<p>3.RSNA 2012 &#8211; Education Exhibit Award, Certificate of Merit<\/p>\n<p>Tanabe Y, Sugawara Y, Takahata H, Sakai S, Takahashi T, Shimizu T, Kajihara M, Hosokawa K. Role of integrated FDG-PET\/CT with dynamic contrast-enhancement in evaluation of gallbladder tumors. RSNA 2012, 98th Scientific Assembly and Annual Meeting (Chicago, Nov, 2012)<\/p>\n<p>4.RSNA 2012 &#8211; Trainee Research Prize<\/p>\n<p>Matsuda T, Miyagawa M, Nakamura M, Yokoyama R, Nishiyama Y, Kawaguchi N, Kido To, Kido Te, MD, Kurata A, Mochizuki T. Characteristics of cardiac F-18 FDG accumulation on PET\/CT in patients with atrial fibrillation. The RSNA 98th Scientific Assembly and Annual Meeting. (2012.11, Chicago)<\/p>\n<p>5.Best Research Award Gold\u3000\uff08\u7b2c22\u56de\u65e5\u672c\u5fc3\u8840\u7ba1\u753b\u50cf\u52d5\u614b\u5b66\u4f1a\uff09<\/p>\n<p>\u57ce\u6238\u502b\u4e4b<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"template":"","class_list":["post-173","results","type-results","status-publish","hentry"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/results\/173","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/results"}],"about":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/types\/results"}],"wp:attachment":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/media?parent=173"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}